A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

NCT07441642 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

272

Enrollment

INDUSTRY

Sponsor class

Conditions

Geographic Atrophy Secondary to Age-related Macular Degeneration

Interventions

DRUG: FWY003
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals